載入...
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
The risk of hepatocellular carcinoma recurrence is universal regardless of the treatment modality applied, and secondary prevention is still an unmet issue even though the elimination of hepatitis C (HCV) with direct antiviral agents (DAAs) was expected to be one of the new options. Unfortunately, t...
Na minha lista:
| 發表在: | Viruses |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563506/ https://ncbi.nlm.nih.gov/pubmed/31052463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11050406 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|